[Translation] A Phase I study to evaluate the pharmacokinetics and safety of a single oral dose of Olorofim in healthy Chinese subjects
本临床试验的主要目的是在中国健康受试者中评估Olorofim单次口服给药的PK,次要目的是在中国健康受试者中评估Olorofim单次口服给药的安全性和耐受性。
[Translation] The primary purpose of this clinical trial is to evaluate the PK of a single oral dose of Olorofim in Chinese healthy subjects, and the secondary purpose is to evaluate the safety and tolerability of a single oral dose of Olorofim in Chinese healthy subjects.